Clinic
Kaiser Permanente
Kaiser Permanente was paid $1.44M by Medicaid between Jan 2018 and Nov 2024, across 130 billing codes. Its largest line is 0450, Emergency room services — 17% of everything it billed.
33Billing provider infoKAISER PERMANENTE
LOS ANGELES, CA 90056
LOS ANGELES, CA 90056
33aNPI1841492212assigned 06/05/2007
33bProvider typeAdult Mental Health Clinic/Center
28Total paid$1.44M
24GClaims221,993
24DCodes billed130
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Adult Mental Health Clinic/Center providers in California
Rank by total paid#50 of 99
Median peer was paid$1.44M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,666 | $117K | |
| 2019 | 15,350 | $149K | |
| 2020 | 17,802 | $143K | |
| 2021 | 34,063 | $363K | |
| 2022 | 44,505 | $442K | |
| 2023 | 55,973 | $192K | |
| 2024incomplete | 29,634 | $37K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 17% | 16,999 | 14,972 | $251K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 16% | 10,264 | 8,845 | $236K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 7.7% | 4,398 | 4,111 | $111K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.9% | 1,042 | 1,004 | $85K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.9% | 938 | 920 | $85K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.5% | 3,009 | 2,721 | $50K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 12,631 | 11,343 | $42K |
| 80051 | 2.8% | 13,206 | 11,596 | $40K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.1% | 2,182 | 1,974 | $31K |
| 82565 | 2.1% | 13,603 | 12,031 | $30K | |
| 84702 | 1.6% | 3,546 | 3,236 | $23K | |
| 84520 | 1.4% | 12,535 | 11,103 | $20K |
118 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 1,161 | $20K |
| 84484 | 1.4% | 4,130 | $20K | |
| 82947 | 1.3% | 12,047 | $19K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 1,186 | $19K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 1,174 | $18K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 808 | $16K |
| 76830 | Ultrasound, transvaginal | 1.1% | 506 | $16K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.1% | 529 | $16K |
| 84460 | 1.1% | 6,524 | $15K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.0% | 4,968 | $15K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.0% | 341 | $15K |
| 83690 | <1% | 4,739 | $13K | |
| 82247 | <1% | 6,063 | $13K | |
| 84450 | <1% | 5,706 | $13K | |
| 84075 | <1% | 5,580 | $12K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,674 | $12K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 784 | $12K |
| 83880 | <1% | 1,228 | $11K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 597 | $10K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,102 | $9K |
| 0111 | <1% | 16 | $9K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 154 | $8K |
| 87088 | <1% | 2,493 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 925 | $8K |
| 85027 | <1% | 1,826 | $6K | |
| 81003 | <1% | 7,080 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,198 | $5K |
| 85610 | <1% | 3,077 | $5K | |
| 82248 | <1% | 2,690 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 219 | $5K |
| 82310 | <1% | 2,363 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,761 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 503 | $5K |
| 87040 | <1% | 1,456 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,541 | $5K |
| 90686 | <1% | 846 | $4K | |
| 83605 | <1% | 1,113 | $4K | |
| 82077 | <1% | 1,128 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,231 | $4K |
| 83735 | <1% | 1,176 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,268 | $3K |
| 80306 | <1% | 442 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 254 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 437 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 92 | $3K |
| 86901 | <1% | 1,238 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 46 | $2K |
| 86900 | <1% | 1,232 | $1K | |
| 80179 | <1% | 369 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 170 | $1K |
| 86780 | <1% | 246 | $1K | |
| 86885 | <1% | 557 | $1K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 60 | $1K |
| 73610 | <1% | 62 | $843.92 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $769.40 |
| 85379 | <1% | 191 | $760.01 | |
| 80061 | Lipid panel | <1% | 76 | $716.56 |
| 86141 | <1% | 281 | $690.51 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $642.96 |
| 87210 | <1% | 226 | $608.22 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 117 | $522.98 |
| 73562 | <1% | 37 | $455.82 | |
| 99283 | Emergency room visit (moderate) | <1% | 234 | $444.59 |
| 86803 | <1% | 44 | $439.22 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 175 | $365.52 |
| J3490 | Unclassified drugs | <1% | 1,220 | $358.31 |
| 0301 | <1% | 657 | $303.32 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 37 | $285.26 |
| 87340 | <1% | 28 | $237.93 | |
| 73030 | <1% | 13 | $224.48 | |
| 87186 | <1% | 54 | $216.03 | |
| 84100 | <1% | 125 | $197.55 | |
| 90688 | <1% | 15 | $189.04 | |
| 86762 | <1% | 13 | $171.14 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 108 | $154.62 |
| 0637 | <1% | 11,709 | $152.10 | |
| 73630 | <1% | 15 | $151.83 | |
| 86787 | <1% | 12 | $149.74 | |
| 85730 | <1% | 64 | $144.96 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $127.42 |
| 90674 | <1% | 36 | $123.04 | |
| 90656 | <1% | 43 | $122.74 | |
| 73130 | <1% | 12 | $118.28 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 87 | $106.74 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 60 | $106.20 |
| 0710 | <1% | 14 | $103.74 | |
| 0250 | <1% | 2,900 | $100.09 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 101 | $97.56 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 18 | $94.40 |
| 85652 | <1% | 111 | $75.15 | |
| 87081 | <1% | 56 | $67.36 | |
| 82962 | <1% | 196 | $39.82 | |
| J1815 | Injection, insulin, per 5 units | <1% | 18 | $39.46 |
| 80320 | <1% | 172 | $37.20 | |
| 82040 | <1% | 12 | $29.50 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | $24.53 |
| 0258 | <1% | 1,790 | $18.05 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 13 | $13.59 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 98 | $1.39 |
| 0302 | 0% | 434 | $0.00 | |
| 0320 | 0% | 122 | $0.00 | |
| 0260 | 0% | 121 | $0.00 | |
| 0300 | 0% | 147 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 14 | $0.00 |
| 80324 | 0% | 149 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 68 | $0.00 |
| 0307 | 0% | 50 | $0.00 | |
| 0306 | 0% | 196 | $0.00 | |
| 80359 | 0% | 149 | $0.00 | |
| 0305 | 0% | 660 | $0.00 | |
| G0378 | Hospital observation service, per hour | 0% | 26 | $0.00 |
| 99251 | 0% | 33 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 16 | $0.00 |
| 0112 | 0% | 28 | $0.00 | |
| 80329 | 0% | 29 | $0.00 | |
| 0255 | 0% | 16 | $0.00 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 0% | 14 | $0.00 |
| 0370 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSELFA, JIM (DEPARTMENT ADMINISTRATOR)